These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37158666)

  • 21. Structural Basis for Specific Inhibition of tRNA Synthetase by an ATP Competitive Inhibitor.
    Fang P; Han H; Wang J; Chen K; Chen X; Guo M
    Chem Biol; 2015 Jun; 22(6):734-44. PubMed ID: 26074468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.
    Hoen R; Novoa EM; López A; Camacho N; Cubells L; Vieira P; Santos M; Marin-Garcia P; Bautista JM; Cortés A; Ribas de Pouplana L; Royo M
    Chembiochem; 2013 Mar; 14(4):499-509. PubMed ID: 23444099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
    Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation.
    Sudhakar R; Adhikari N; Pamnani S; Panda A; Bhattacharjee M; Rizvi Z; Shehzad S; Gupta D; Sijwali PS
    Microbiol Spectr; 2022 Jun; 10(3):e0278121. PubMed ID: 35616371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
    Looker O; Dans MG; Bullen HE; Sleebs BE; Crabb BS; Gilson PR
    Traffic; 2022 Sep; 23(9):442-461. PubMed ID: 36040075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of melatonin derivatives on human malaria parasite Plasmodium falciparum.
    Srinivasan V; Zakaria R; Mohamed M; Saleh RM
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(2):102-8. PubMed ID: 24935182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as
    Okaniwa M; Shibata A; Ochida A; Akao Y; White KL; Shackleford DM; Duffy S; Lucantoni L; Dey S; Striepen J; Yeo T; Mok S; Aguiar ACC; Sturm A; Crespo B; Sanz LM; Churchyard A; Baum J; Pereira DB; Guido RVC; Dechering KJ; Wittlin S; Uhlemann AC; Fidock DA; Niles JC; Avery VM; Charman SA; Laleu B
    ACS Infect Dis; 2021 Jun; 7(6):1680-1689. PubMed ID: 33929818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-guided conversion from an anaplastic lymphoma kinase inhibitor into Plasmodium lysyl-tRNA synthetase selective inhibitors.
    Zhou J; Xia M; Huang Z; Qiao H; Yang G; Qian Y; Li P; Zhang Z; Gao X; Jiang L; Wang J; Li W; Fang P
    Commun Biol; 2024 Jun; 7(1):742. PubMed ID: 38890421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE EFFICACY OF MARINE NATURAL PRODUCTS AGAINST PLASMODIUM FALCIPARUM.
    Goto Y; Kamihira R; Nakao Y; Nonaka M; Takano R; Xuan X; Kato K
    J Parasitol; 2021 Mar; 107(2):284-288. PubMed ID: 33844839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs.
    Choi SR; Mukherjee P; Avery MA
    Curr Med Chem; 2008; 15(2):161-71. PubMed ID: 18220771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.
    Verlinden BK; de Beer M; Pachaiyappan B; Besaans E; Andayi WA; Reader J; Niemand J; van Biljon R; Guy K; Egan T; Woster PM; Birkholtz LM
    Bioorg Med Chem; 2015 Aug; 23(16):5131-43. PubMed ID: 25684422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.
    Ross LS; Fidock DA
    Cell Host Microbe; 2019 Jul; 26(1):35-47. PubMed ID: 31295423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of modulators in Plasmodium falciparum resistance to antimalarials].
    Verdier F; Pussard E
    Med Trop (Mars); 1995; 55(4 Suppl):27-32. PubMed ID: 8649262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsymmetrical Bisquinolines with High Potency against
    Liebman KM; Burgess SJ; Gunsaru B; Kelly JX; Li Y; Morrill W; Liebman MC; Peyton DH
    Molecules; 2020 May; 25(9):. PubMed ID: 32397659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.